Cytosorbents
CTSO
$0.82
Share price
1.24%
Change (1 day)
-66.71%
Change (1 year)
Categories
Cytosorbents (CTSO) - Net assets
Net assets on the balance sheet as of December 2023 : $23.27 M
According to Cytosorbents's latest financial reports the company has $23.27 M in net assets.
A company’s net assets is the sum of its assets minus the sum of its liabilities.
Cytosorbents - Net assets on balance sheet (from 2005 to 2023)
Net assets by year
| Year | Net assets | Change |
|---|---|---|
| 2022-12-31 | $35.37 M | -43.47% |
| 2021-12-31 | $62.57 M | -21% |
| 2020-12-31 | $79.21 M | 2217.57% |
| 2019-12-31 | $3.41 M | -79.82% |
| 2018-12-31 | $16.93 M | 65.01% |
| 2017-12-31 | $10.26 M | 667.34% |
| 2016-12-31 | $1.33 M | -83.71% |
| 2015-12-31 | $8.21 M | 107.17% |
| 2014-12-31 | $3.96 M | -127.78% |
| 2013-12-31 | $-14.27 M | 22.71% |
| 2012-12-31 | $-11.63 M | 15.21% |
| 2011-12-31 | $-10.1 M | 1982.22% |
| 2010-12-31 | $-0.49 M | -138.22% |
| 2009-12-31 | $1.26 M | -46.27% |
| 2008-12-31 | $2.35 M | -2362.29% |
| 2007-12-31 | $-0.11 M | -104.41% |
| 2006-12-31 | $2.36 M |
Net assets for similar companies or competitors
| Company | Net assets | differencediff. | Country |
|---|---|---|---|
 Boston Scientific BSX | $19.53 B | 83,809.05% | 🇺🇸 USA |
 Hologic HOLX | $4.65 B | 19,894.67% | 🇺🇸 USA |
 Meridian Bioscience VIVO | $0.36 B | 1,481.34% | 🇺🇸 USA |